Esketamine outperforms real-world management for treatment-resistant depression: preliminary results Presented ByMr Joachim Morrens , Janssen EMEA, Belgium TrialPhase 3, SUSTAIN-2; EOTC ConferenceECNP 2021 26 November, 2021 11:42